Virtu Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Virtu Financial’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,471	Closed	-$727K	–	2066
2025 Q2	$727K	Buy	+15,471	New	+$688K	0.04%	437
2022 Q3	–	Sell	-10,329	Closed	-$254K	–	2223
2022 Q2	$254K	Buy	10,329 +5,523	+115%	+$202K	0.02%	653
2022 Q1	$271K	Sell	4,806 -826	-15%	-$47.3K	0.02%	634
2021 Q4	$349K	Buy	+5,632	New	+$373K	0.04%	536

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Virtu Financial's SWTX Position: Q3 2025 in Review

Virtu Financial sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 15,471 shares — an estimated $727K sold.

Virtu Financial first reported a position in SWTX in Q4 2021 and held it in 4 quarters. The position peaked at $727K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Virtu Financial reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Virtu Financial sold 15,471 SpringWorks Therapeutics shares in Q3 2025, an estimated $727K.
Virtu Financial first reported a position in SpringWorks Therapeutics in Q4 2021 and held it in 4 quarters.
Virtu Financial's SpringWorks Therapeutics position peaked at $727K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.